Strategic partnerships Heraeus Medical is actively engaging with supply chain collaborators and NHS entities to validate production processes for Palacos bone cement, presenting an opportunity to align procurement timelines, compliance requirements, and volume commitments with healthcare systems and distributors.

Expansion into regenerative The company expanded into resorbable biomaterials with the launch of heracure at DKOU 2025, signaling a growth area in regenerative orthopedics that could open cross-sell opportunities with surgeons and hospitals seeking advanced biomaterials and related training.

Innovation recognition Repeated recognitions for innovation and top appraisals in medical devices demonstrate credibility with hospital procurement and C-suite buyers, facilitating conversations around premium products, education programs, and long-term partnerships.

Antibiotic-loaded growth Portfolio emphasis on single and dual antibiotic loaded bone cements positions Heraeus as a partner for infection prevention initiatives, enabling targeted outreach to infection control committees, orthopedic wards, and perioperative teams seeking evidence-based solutions.

Global gold standard PALACOS bone cement’s long-standing reputation and scale (over 40 million procedures) suggests a differentiator in tenders and hospital standardization efforts, creating opportunities for volume-based contracts, training curricula, and clinical support programs.